[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN115537388A - Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof - Google Patents

Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof Download PDF

Info

Publication number
CN115537388A
CN115537388A CN202211249948.1A CN202211249948A CN115537388A CN 115537388 A CN115537388 A CN 115537388A CN 202211249948 A CN202211249948 A CN 202211249948A CN 115537388 A CN115537388 A CN 115537388A
Authority
CN
China
Prior art keywords
recombinant
growth factor
mesenchymal stem
serum
bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211249948.1A
Other languages
Chinese (zh)
Inventor
高寒
梁逸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Ji Mi Biotechnology Co ltd
Original Assignee
Hangzhou Ji Mi Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Ji Mi Biotechnology Co ltd filed Critical Hangzhou Ji Mi Biotechnology Co ltd
Priority to CN202211249948.1A priority Critical patent/CN115537388A/en
Publication of CN115537388A publication Critical patent/CN115537388A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/44Thiols, e.g. mercaptoethanol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/46Amines, e.g. putrescine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/105Insulin-like growth factors [IGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a serum-free culture medium for bovine adipose-derived mesenchymal stem cells, which is suitable for cell culture meat, belongs to the technical field of animal cell culture, and comprises DMEM basic culture, L-alanyl-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt. Repeated experiments prove that the inventor obtains a novel bovine Adipose-derived mesenchymal stem cell (ADSC) serum-free culture medium, and can effectively culture the bovine Adipose mesenchymal stem cells.

Description

Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof
Technical Field
The invention belongs to the technical field of animal cell culture, and particularly relates to a bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and a preparation method thereof.
Background
Compared with plant meat and fermented meat made of microorganisms, the cell culture meat is novel meat which is closest to traditional meat. The cell culture meat has the advantages of no microbial pollution, high-quality protein content, good eating experience and the like, and the carbon footprint and water resource requirements in the production process are much lower than those of the traditional livestock breeding, so that the cell culture meat is one of the most promising development directions in the future culture of meat substitutes. Meanwhile, the technical barrier of the cell culture meat industry is also higher and more challenging. Among them, the development of a low-cost animal-derived component-free medium suitable for cell culture meat is an important basis for cell culture meat to meet food safety standards and eventually to be able to enter mass production.
Mesenchymal Stem Cells (MSCs) are derived from the mesoderm in the early embryonic development stage, are adult Stem Cells which have the potential of self-renewal and multidirectional differentiation and can still maintain the biological characteristics thereof after in vitro large-scale amplification, and can proliferate and differentiate to various tissues such as bone, cartilage, muscle, ligament, tendon, fat and stromal Cells. Therefore, mesenchymal stem cells are one of the important cell sources for culturing meat.
At present, the media used to culture MSCs are mainly of the following types: one is a basal medium (such as alpha-MEM medium, DMEM medium, etc.) supplemented with 5-20% animal serum. However, animal serum is expensive and has a limited yield, and is not suitable for large-scale production of cell culture meat. In addition, animal serum may have mycoplasma, prion and other pollution, and human xenoprotein pollution or allergy and other risks, and is difficult to meet edible standards; the second category is the addition of serum replacement (e.g., human platelet lysate, etc.) to basal media. However, the culture medium has animal-derived components, has unknown protein, has the defects of large batch difference, unstable source and the like, and is not suitable for producing cell culture meat on a large scale; the third type is to supplement serum substitute components which are not derived from animals and have definite chemical components in a basal culture medium, so that the nutrient requirement of cells can be met, and the natural defects of the first two types of culture media can be avoided. Therefore, the cell culture medium which is suitable for the growth of the MSCs and has definite chemical formula and low cost is an important prerequisite for the development of large-scale production of cell culture meat.
Disclosure of Invention
Aiming at the existing problems, the inventor obtains a novel serum-free culture medium of bovine Adipose-derived mesenchymal stem cells (ADSCs) through repeated experimental verification, and can effectively culture the bovine Adipose mesenchymal stem cells.
The invention is realized by the following technical scheme:
a bovine adipose-derived mesenchymal stem cell serum-free culture medium suitable for cell culture meat comprises a DMEM basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-alanyl-L-glutamine, 0-5.5mg/L of recombinant transferrin, 0-10mg/L of recombinant bovine insulin, 0.001-0.01mg/L of sodium selenite, 0.1-2mg/L of zinc sulfate heptahydrate, 10-50ng/mL of cortisol, 0.1-1.5mg/mL of recombinant human albumin, 1-10ng/mL of recombinant basic fibroblast growth factor, 1-2 ng/mL of recombinant transforming growth factor beta, 5-20ng/mL of recombinant insulin-like growth factor, 2-100mg/mL of ethanolamine, 0.1-3mg/L of mercaptoethanol and 10-50mg/L of 2-phosphate-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
Preferably, the culture medium comprises a DMEM basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-propylamino-L-glutamine, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phosphoric acid-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
A preparation method of a bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture meat comprises the following steps:
(1) Preparing the corresponding concentrations for later use: 43.5mg/L of L-alanyl-L-glutamine, 1mg/L of recombinant transferrin, 5mg/L of recombinant bovine insulin, 0.4mg/L of sodium selenite, 0.01g/L of zinc sulfate heptahydrate, 0.5mg/mL of cortisol, 0.1g/mL of recombinant human serum albumin, 10 mug/mL of recombinant basic fibroblast growth factor, 100 mug/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 10mg/L of mercaptoethanol and 0.1g/L of sodium 2-phosphate-L-ascorbate;
(2) Filtering with 0.2 μm low protein adsorption filter membrane;
(3) And adding the filtered L-propylamino-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor-beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt solution into a DMEM basic culture medium, and uniformly mixing to obtain the serum-free culture medium of the bovine adipose-derived mesenchymal stem cells.
Compared with the prior art, the invention has the following advantages:
1. the culture medium has no animal-derived components, has controllable infection risk and meets the food production standard;
2. the components contained in the culture medium are all derived from recombinant proteins or chemically synthesized, and the components are clear;
3. when the culture medium prepared by the method is applied, a culture dish or a culture bottle does not need to be coated in advance;
4. when the culture medium prepared by the method is applied, the adherence of cells is good, and the cell morphology has no obvious difference with that of serum cultured cells;
5. when the culture medium prepared by the method is applied, the cell proliferation rate is high, the price is relatively low, and the method is suitable for large-scale cell culture.
Drawings
FIG. 1 shows the results of a Plackett-Burman experiment for screening of first batch of medium components;
FIG. 2 shows the results of a Plackett-Burman experiment for the second batch of media composition screening;
FIG. 3 is a graph comparing P7 generation bovine adipose derived mesenchymal stem cells with other brands of serum-free medium and 10% serum medium.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings and examples.
The components of the present invention may be selected from conventional commercially available products (Table 1).
TABLE 1 serum-free Medium composition information
Figure BDA0003887292890000031
Figure BDA0003887292890000041
Example 1 selection of serum-free Medium Components of bovine adipose-derived mesenchymal Stem cells
The screening method comprises the following steps: two batches of the Plackett-Burman experiment design (tables 2, 3) were run separately for various components in serum-free medium, with 12 treatment groups per batch of the Plackett-Burman experiment, and 3 replicates per treatment group. In the first experiment, two concentration levels of ITS (%), fibronectin (FN, μ g/mL), recombinant human serum albumin (ReHA, mg/mL), recombinant basic fibroblast growth factor (FGF 2, ng/mL), recombinant insulin-like growth factor (IGF 1, ng/mL), recombinant epidermal growth factor (EGF, ng/mL), recombinant transforming growth factor beta 1 (TGF beta 1, ng/mL) and recombinant vascular endothelial growth factor (VEGF, ng/mL) were screened, the concentration levels being determined by reference and earlier experiments.
TABLE 2 first batch Medium composition screening Plackett-Burman Experimental design
Treatment group ITS FN ReHA FGF2 IGF1 EGF TGFβ1 VEGF
1 0 0 0.8 10 5 0 0 0
2 5 2 0.8 0 0 0 0 5
3 5 2 0 0 5 0 0.5 0
4 0 2 0.8 0 5 10 0 5
5 0 2 0.8 10 0 10 0.5 0
6 5 0 0.8 0 5 10 0.5 0
7 5 0 0 10 5 10 0 5
8 0 0 0 0 0 10 0.5 5
9 0 0 0 0 0 0 0 0
10 5 2 0 10 0 10 0 0
11 5 0 0.8 10 0 0 0.5 5
12 0 2 0 10 5 0 0.5 5
After 72h of cell culture with 12 experimental formulations, the cells were counted and the results of 12 treatment groups were analyzed (fig. 1). The results show that the addition of ITS, reHA, FGF2, IGF and TGF beta 1 promotes cell proliferation and is therefore retained in the medium formulation
Two concentration levels of sodium selenite (SS, 0 and 0.01%), ferric citrate (FC, μ g/mL), zinc sulfate heptahydrate (ZnSO 4, mg/L), hydrocortisone (h.c., ng/mL), ethanolamine (ethan., mg/L), mercaptoethanol (EGF, mg/L), HEPES buffer (mg/L) and sodium 2-phospho-L-ascorbate (P _ LAA, μ g/mL) were screened in the second experiment.
TABLE 3 second batch Medium composition screening Plackett-Burman Experimental design
Treatment group SS FC ZnSO4 H.C. Ethan. ME HEPES P_LAA
1 0 0 10 25 50 0 0 0
2 0.01 2 1 0 0 0 0 20
3 0.01 2 0 0 50 0 3000 0
4 0 2 1 0 50 2.2 0 20
5 0 2 1 25 0 2.2 3000 0
6 0.01 0 1 0 50 2.2 3000 0
7 0.01 0 0 25 50 2.2 0 20
8 0 0 0 0 0 2.2 3000 20
9 0 0 0 0 0 0 0 0
10 0.01 2 0 25 0 2.2 0 0
11 0.01 0 1 25 0 0 3000 20
12 0 2 0 25 50 0 3000 20
After 72h of cell culture with 12 experimental formulations, the cells were counted and the results of 12 treatment groups were analyzed (fig. 2). The results show that the addition of sodium selenite, zinc sulfate heptahydrate, hydrocortisone, ethanolamine, mercaptoethanol and sodium 2-phospho-L-ascorbate promotes cell proliferation and is therefore retained in the medium formulation. While ferric citrate and HEPES buffer did not promote in the current formulations and therefore were not retained in the culture medium.
EXAMPLE 2 determination of the proportion of the major constituents of serum-free Medium
After determining each component of the culture medium, the mixture ratio of the components of the culture medium screened in two batches is optimized through two times of orthogonal experimental design (tables 4 and 5). Each time, 12 treatment groups were tested orthogonally, with 3 replicates per treatment group, each component being designed for both high and low concentration levels.
TABLE 4 first orthogonal experimental design
Figure BDA0003887292890000051
Figure BDA0003887292890000061
TABLE 5 second orthogonal design of experiment
Treatment group SS ZnSO4 H.C. Ethan. ME P_LAA
1 0.005 1 25 50 0.1 5
2 0.01 1 50 2 0.1 30
3 0.01 2 50 50 0.1 5
4 0.005 1 50 50 2.2 30
5 0.005 1 25 2 2.2 5
6 0.01 1 50 50 2.2 5
7 0.01 2 25 50 2.2 30
8 0.005 2 50 2 2.2 30
9 0.005 2 50 2 0.1 5
10 0.01 2 25 2 2.2 5
11 0.01 1 25 2 0.1 30
12 0.005 2 25 50 0.1 30
As a result, it was found that: the bovine adipose-derived mesenchymal stem cells cultured by adopting the following mixture ratio have the advantages of optimal shape, higher proliferation efficiency and lower overall cost of the culture medium: the culture medium comprises a DMEM high-glycosyl basic culture medium, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phospho-L-ascorbic acid sodium salt. In addition, the medium was supplemented with 75mg/L L-propylamino-L-glutamine as a supplemental nitrogen source.
Example 3 comparison of the minimal Medium formulation with serum Medium and commercial serum-free Medium
According to the formula of the culture medium determined by the invention, a serum-free culture medium is prepared. Meanwhile, a conventionally used serum culture medium is prepared: adding fetal calf serum into DMEM high-sugar medium according to the proportion of 10%, and then adding recombinant basic fibroblast growth factor with the concentration of 5 ng/mL. The two culture mediums are compared with a serum-free mesenchymal stem cell culture medium of a certain brand on the market. First, bovine adipose-derived mesenchymal stem cells cultured adherently were digested with 0.25% trypsin, added to two media at a concentration of 3 ten thousand cells per mL, and placed in 12-well plates at a volume of 1mL per well. Placing 12-well culture plates at 37 deg.C, 5% CO 2 And culturing in a cell culture box with saturated humidity, observing the cell state after culturing for 72h, and counting the concentration of living cells. Fig. 3 is a graph comparing P7 generation bovine adipose-derived mesenchymal stem cells cultured in three different media. As can be seen from the figure, the cells cultured by the three culture media are all spindle-shaped and fiber-like, which indicates that the serum-free culture medium can maintain better cell morphology. The cell counting result shows that the serum-free culture medium can reach the same level of the commercial serum-free culture medium in terms of cell proliferation, and the proliferation promoting efficiency is higher than that of a 10% serum culture medium.

Claims (3)

1. The serum-free culture medium for the bovine adipose-derived mesenchymal stem cells is suitable for cell culture of meat, and is characterized by comprising a DMEM basic culture medium and further comprising the following components in concentration: 75mg/L of L-alanyl-L-glutamine, 0-5.5mg/L of recombinant transferrin, 0-10mg/L of recombinant bovine insulin, 0.001-0.01mg/L of sodium selenite, 0.1-2mg/L of zinc sulfate heptahydrate, 10-50ng/mL of cortisol, 0.1-1.5mg/mL of recombinant human albumin, 1-10ng/mL of recombinant basic fibroblast growth factor, 1-2 ng/mL of recombinant transforming growth factor beta, 5-20ng/mL of recombinant insulin-like growth factor, 2-100mg/mL of ethanolamine, 0.1-3mg/L of mercaptoethanol and 10-50mg/L of 2-phosphate-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
2. The serum-free culture medium for the bovine adipose-derived mesenchymal stem cells, which is suitable for cell culture of meat, according to claim 1, comprises a DMEM (DMEM) basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-propylamino-L-glutamine, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phosphoric acid-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500 mg/LD-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
3. The method for preparing the serum-free medium for the bovine adipose-derived mesenchymal stem cells suitable for cell culture of meat according to claim 1, which comprises the following steps:
(1) Preparing the corresponding concentrations for later use: 43.5mg/L of L-alanyl-L-glutamine, 1mg/L of recombinant transferrin, 5mg/L of recombinant bovine insulin, 0.4mg/L of sodium selenite, 0.01g/L of zinc sulfate heptahydrate, 0.5mg/mL of cortisol, 0.1g/mL of recombinant human serum albumin, 10 ug/mL of recombinant basic fibroblast growth factor, 100 ug/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 10mg/L of mercaptoethanol and 0.1g/L of sodium salt of 2-phospho-L-ascorbic acid;
(2) Filtering with 0.2 μm low protein adsorption filter membrane;
(3) And adding the filtered L-propylamino-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor-beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt solution into a DMEM basic culture medium, and uniformly mixing to obtain the serum-free culture medium of the bovine adipose-derived mesenchymal stem cells.
CN202211249948.1A 2022-10-12 2022-10-12 Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof Pending CN115537388A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211249948.1A CN115537388A (en) 2022-10-12 2022-10-12 Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211249948.1A CN115537388A (en) 2022-10-12 2022-10-12 Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115537388A true CN115537388A (en) 2022-12-30

Family

ID=84732631

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211249948.1A Pending CN115537388A (en) 2022-10-12 2022-10-12 Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115537388A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107557331A (en) * 2017-09-15 2018-01-09 上海莱馥医疗科技有限公司 A kind of method for separating and cultivating human adipose-derived stem cell
CN110923196A (en) * 2019-12-03 2020-03-27 广州赛莱拉干细胞科技股份有限公司 Serum-free medium, preparation method thereof and mesenchymal stem cell culture method
CN112608891A (en) * 2020-12-18 2021-04-06 云南中科灵长类生物医学重点实验室 Mesenchymal stem cell serum-free medium and application thereof
CN113736729A (en) * 2021-08-25 2021-12-03 生物岛实验室 Composition, stem cell serum-free culture medium containing composition and stem cell culture method
US20220073870A1 (en) * 2020-06-05 2022-03-10 Upside Foods, Inc. Nutrient media for the production of slaughter-free meat

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107557331A (en) * 2017-09-15 2018-01-09 上海莱馥医疗科技有限公司 A kind of method for separating and cultivating human adipose-derived stem cell
CN110923196A (en) * 2019-12-03 2020-03-27 广州赛莱拉干细胞科技股份有限公司 Serum-free medium, preparation method thereof and mesenchymal stem cell culture method
US20220073870A1 (en) * 2020-06-05 2022-03-10 Upside Foods, Inc. Nutrient media for the production of slaughter-free meat
CN112608891A (en) * 2020-12-18 2021-04-06 云南中科灵长类生物医学重点实验室 Mesenchymal stem cell serum-free medium and application thereof
CN113736729A (en) * 2021-08-25 2021-12-03 生物岛实验室 Composition, stem cell serum-free culture medium containing composition and stem cell culture method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATRIKOSKI M等: "Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells", 《STEM CELL RES THER》, vol. 04, no. 02, 7 March 2013 (2013-03-07), pages 1 - 15 *
任春红等: "无动物源成分培养基用于人脐带间充质干细胞培养的研究", 《延安大学学报(医学科学版)》, vol. 13, no. 01, 15 March 2015 (2015-03-15), pages 1 - 4 *

Similar Documents

Publication Publication Date Title
Lee et al. Review of the current research on fetal bovine serum and the development of cultured meat
CN103911339B (en) A kind of serum-free fibroblast culture medium and preparation method thereof
JP4532493B2 (en) Cell culture media
US20220204923A1 (en) Chemically defined medium for differentiation of muscle stem cells in vitro
IL142914A (en) Serum free medium for chondrocyte-like cells
CN113736729B (en) Composition, serum-free medium containing composition and stem cell culture method
CN112961825B (en) Serum-free medium and preparation method thereof
US20230117670A1 (en) Bioactive substance composition, serum-free medium comprising the composition, and uses thereof
CN112608891A (en) Mesenchymal stem cell serum-free medium and application thereof
US20230083026A1 (en) Serum-free medium for culturing a bovine progenitor cell
CN114480273A (en) Culture medium for obtaining mesenchymal stem cells and exosomes thereof and preparation method thereof
CN111206017A (en) Serum-free culture medium for stem cells and application thereof
CN114574433B (en) Culture medium with definite chemical components for in-vitro proliferation of myogenic cells
WO2003050273A1 (en) Human cell culture medium and culture method
CN110699317A (en) Human umbilical cord mesenchymal stem cell serum-free medium and preparation method and application thereof
CN115537388A (en) Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof
US20240254453A1 (en) Cell culture medium and supplements for corneal and skin cell culture
KR102679956B1 (en) Method of culturing muscle cells for producing cattle cultured meat
CN117957308A (en) Cell culture medium and supplement for cell meat production
CN112708598A (en) Neural precursor cell culture medium without serum component and preparation method and application thereof
CN110684735A (en) Culture medium for rapidly proliferating neural stem cells
CN112126622B (en) Primary isolated culture method of umbilical cord mesenchymal stem cells capable of improving yield
CN117535237A (en) Human umbilical cord mesenchymal stem cell culture medium and preparation method thereof
CN116478914A (en) Serum-free cell culture system and cell digestion stopping solution thereof
CN115896008A (en) Low-serum culture medium and application thereof in preparation of cell culture meat of large yellow croaker

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination